Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_assertion type Assertion NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_head.
- NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_assertion description "[Truncation mutations of ASXL1 occur in colorectal cancers with microsatellite instability (MSI), malignant myeloid diseases, chronic lymphocytic leukaemia, head and neck squamous cell carcinoma, and liver, prostate and breast cancers; those of ASXL2 occur in prostate cancer, pancreatic cancer and breast cancer and those of ASXL3 are observed in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_provenance.
- NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_assertion evidence source_evidence_literature NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_provenance.
- NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_assertion SIO_000772 23736028 NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_provenance.
- NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_assertion wasDerivedFrom befree-2016 NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_provenance.
- NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_assertion wasGeneratedBy ECO_0000203 NP1083320.RA8JY0XZ8aDrNipjJSby6RlbjImu8yHHrNnfD6HYTDhtg130_provenance.